Rhumbline Advisers cut its stake in shares of Mylan NV (NASDAQ:MYL) by 1.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 751,173 shares of the company’s stock after selling 14,315 shares during the quarter. Rhumbline Advisers owned approximately 0.15% of Mylan worth $27,493,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. State of Alaska Department of Revenue boosted its position in shares of Mylan by 5.3% in the third quarter. State of Alaska Department of Revenue now owns 74,135 shares of the company’s stock valued at $2,712,000 after acquiring an additional 3,707 shares during the period. Bellevue Group AG boosted its position in shares of Mylan by 114.7% in the second quarter. Bellevue Group AG now owns 502,350 shares of the company’s stock valued at $18,155,000 after acquiring an additional 268,400 shares during the period. Andra AP fonden boosted its position in shares of Mylan by 11.5% in the third quarter. Andra AP fonden now owns 140,200 shares of the company’s stock valued at $5,131,000 after acquiring an additional 14,500 shares during the period. Burney Co. boosted its position in shares of Mylan by 18.4% in the second quarter. Burney Co. now owns 128,245 shares of the company’s stock valued at $4,635,000 after acquiring an additional 19,914 shares during the period. Finally, Schwab Charles Investment Management Inc. boosted its position in shares of Mylan by 12.8% in the second quarter. Schwab Charles Investment Management Inc. now owns 2,237,468 shares of the company’s stock valued at $80,863,000 after acquiring an additional 253,082 shares during the period. 81.91% of the stock is currently owned by institutional investors and hedge funds.

Shares of MYL stock opened at $33.91 on Wednesday. Mylan NV has a 12 month low of $30.33 and a 12 month high of $47.82. The firm has a market cap of $17.84 billion, a PE ratio of 7.44, a price-to-earnings-growth ratio of 1.14 and a beta of 1.53. The company has a current ratio of 1.26, a quick ratio of 0.77 and a debt-to-equity ratio of 1.20.

Mylan (NASDAQ:MYL) last announced its earnings results on Monday, November 5th. The company reported $1.25 EPS for the quarter, beating the Zacks’ consensus estimate of $1.19 by $0.06. Mylan had a net margin of 4.71% and a return on equity of 19.39%. The firm had revenue of $2.86 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter in the previous year, the business posted $1.10 EPS. The company’s quarterly revenue was down 4.2% on a year-over-year basis. As a group, analysts expect that Mylan NV will post 4.66 earnings per share for the current year.

A number of equities analysts have recently commented on the stock. Leerink Swann cut their price objective on shares of Mylan from $53.00 to $47.00 and set an “outperform” rating for the company in a research report on Thursday, August 9th. Raymond James lowered shares of Mylan from a “strong-buy” rating to an “outperform” rating in a research report on Thursday, August 9th. Cowen reiterated a “hold” rating and set a $31.00 target price on shares of Mylan in a research report on Thursday, August 9th. Cantor Fitzgerald reiterated a “hold” rating and set a $41.00 target price on shares of Mylan in a research report on Wednesday, August 8th. Finally, Wells Fargo & Co set a $41.00 target price on shares of Mylan and gave the company a “hold” rating in a research report on Wednesday, August 8th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $46.56.

TRADEMARK VIOLATION NOTICE: “Mylan NV (MYL) Shares Sold by Rhumbline Advisers” was published by Watch List News and is owned by of Watch List News. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://www.watchlistnews.com/mylan-nv-myl-shares-sold-by-rhumbline-advisers/2628423.html.

About Mylan

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter (OTC) products worldwide. The company operates through three segments: North America, Europe, and Rest of World. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

Read More: Yield Curve

Institutional Ownership by Quarter for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.